Reference
·Primary source
Thai FDA-Licensed Cosmetic Manufacturers
~2,000–2,500 licensed facilities
Thailand's Thai FDA maintains a registry of approximately 2,000–2,500 licensed cosmetic manufacturing facilities, ranging from GMP-certified international-standard factories to smaller domestic producers. The Cosmetic Act B.E. 2558 (2015) requires all manufacturers to register and comply with GMP guidelines aligned with ASEAN standards. The regulatory burden for export-oriented OEM/ODM operators has increased since the FDA introduced mandatory electronic submission of manufacturing records in 2022. Only a subset of licensed manufacturers — estimated at 200–400 facilities — are capable of handling multinational brand-owner quality audits (ISO 22716 and CGMP), creating a quality tier gap that consolidates high-value contracts among larger OEM operators.
Figure in context
Thailand's Thai FDA maintains a registry of approximately 2,000–2,500 licensed cosmetic manufacturing facilities, ranging from GMP-certified international-standard factories to smaller domestic producers. The Cosmetic Act B.E. 2558 (2015) requires all manufacturers to register and comply with GMP guidelines aligned with ASEAN standards. The regulatory burden for export-oriented OEM/ODM operators has increased since the FDA introduced mandatory electronic submission of manufacturing records in 2022. Only a subset of licensed manufacturers — estimated at 200–400 facilities — are capable of handling multinational brand-owner quality audits (ISO 22716 and CGMP), creating a quality tier gap that consolidates high-value contracts among larger OEM operators.
Thailand's Thai FDA maintains a registry of approximately 2,000–2,500 licensed cosmetic manufacturing facilities, ranging from GMP-certified international-standard factories to smaller domestic producers. The Cosmetic Act B.E. 2558 (2015) requires all manufacturers to register and comply with GMP guidelines aligned with ASEAN standards. The regulatory burden for export-oriented OEM/ODM operators has increased since the FDA introduced mandatory electronic submission of manufacturing records in 2022. Only a subset of licensed manufacturers — estimated at 200–400 facilities — are capable of handling multinational brand-owner quality audits (ISO 22716 and CGMP), creating a quality tier gap that consolidates high-value contracts among larger OEM operators.
Time scope
FY2024
Source basis
Primary source
Interpretation notes
What this tells you
Thailand's Thai FDA maintains a registry of approximately 2,000–2,500 licensed cosmetic manufacturing facilities, ranging from GMP-certified international-standard factories to smaller domestic producers. The Cosmetic Act B.E. 2558 (2015) requires all manufacturers to register and comply with GMP guidelines aligned with ASEAN standards. The regulatory burden for export-oriented OEM/ODM operators has increased since the FDA introduced mandatory electronic submission of manufacturing records in 2022. Only a subset of licensed manufacturers — estimated at 200–400 facilities — are capable of handling multinational brand-owner quality audits (ISO 22716 and CGMP), creating a quality tier gap that consolidates high-value contracts among larger OEM operators.
What not to do with it
Use the linked report for interpretation and keep basis differences explicit.
Related figures
Adjacent numbers that add context without drowning the value.
Thailand Cosmetic OEM/ODM Industry Revenue
Thai FDA, Thai Cosmetic Manufacturers Association, DITP, Department of Business Development
Do Day Dream (DDD) Annual Revenue
Do Day Dream Annual Report, SET filings
Thailand Cosmetic and Personal-Care Export Value
Thai Customs Department, DITP, TCMA
K-Beauty and J-Beauty Contract Manufacturing Share of Thai Cosmetic OEM
TCMA, S&J International Annual Report, DITP market-intelligence briefs
Report context
Atlas actors in this figure's reports
Profiles covered in the report that cite this number.